Cannabis vs Sleep Aids: How THC Compares to Melatonin, Benadryl, Trazodone, and Magnesium
Cannabis & Sleep
5 Compared
Cannabis produces the fastest subjective sleep onset but the worst long-term architecture, while melatonin is safest for circadian issues and trazodone offers the best long-term profile for chronic insomnia.
American Academy of Sleep Medicine, 2017
American Academy of Sleep Medicine, 2017
View as imageWhen cannabis users decide to address their sleep without THC — or when they are looking for something to supplement or replace it — the options can be overwhelming. The pharmacy aisle alone offers melatonin, diphenhydramine (Benadryl, ZzzQuil), magnesium, valerian root, and a dozen other options. Physicians may prescribe trazodone, gabapentin, or other medications. Each one works differently, and the tradeoffs are not obvious from the packaging.
This comparison examines the five most common sleep interventions that cannabis users consider: cannabis itself (THC), melatonin, diphenhydramine, trazodone, and magnesium. The goal is not to rank them from best to worst — that depends entirely on your specific situation — but to make the tradeoffs explicit so you can make an informed choice.
Key Takeaways
- Every sleep aid involves tradeoffs between how fast it works, how it affects sleep quality, whether you build tolerance, side effects, and long-term safety — there is no perfect option, so picking the least-bad fit for your situation is the goal
- Cannabis (THC) gets you to sleep faster than anything else on this list but is the worst for long-term sleep architecture — it builds tolerance within weeks, suppresses REM sleep, and causes withdrawal insomnia that pulls people back in
- Melatonin is the safest choice for circadian-related insomnia with essentially no tolerance, dependence, or withdrawal, but it is not a sedative — it shifts your body clock rather than knocking you out, and most people take 10 to 20 times more than they need
- Diphenhydramine (Benadryl, ZzzQuil) builds tolerance faster than cannabis, impairs memory consolidation during sleep, and has been linked to increased dementia risk with chronic use — the American Academy of Sleep Medicine explicitly says do not use it regularly for sleep
- Trazodone is the most commonly prescribed off-label sleep medication in the United States, with a better long-term profile than cannabis or diphenhydramine — lower abuse potential and less REM suppression — though it has its own side effects
- Magnesium glycinate has the mildest effect but also the lowest risk, and it works best for people whose sleep trouble comes from muscle tension, restlessness, or magnesium deficiency rather than clinical insomnia
Cannabis (THC)
Head-to-Head
Sleep Aids Compared: 5 Key Dimensions
No perfect option — pick the least-bad fit for your situation
Cannabis (THC)
Speed
Tolerance
REM Safe
Long-term Safety
Withdrawal
Melatonin
Speed
Tolerance
REM Safe
Long-term Safety
Withdrawal
Benadryl
Speed
Tolerance
REM Safe
Long-term Safety
Withdrawal
Trazodone
Speed
Tolerance
REM Safe
Long-term Safety
Withdrawal
Magnesium
Speed
Tolerance
REM Safe
Long-term Safety
Withdrawal
AASM: do not use Benadryl regularly for sleep
Sleep Aid ComparisonHow it works. THC binds to CB1 receptors in brain regions that regulate wakefulness and sleep, producing sedation and reducing sleep latency. It also suppresses REM sleep and, with chronic use, disrupts sleep architecture across all stages.
What it does well. Cannabis produces the fastest subjective sleep onset of any option in this comparison. For people whose primary problem is an inability to fall asleep, THC delivers immediate results. No other option on this list produces the same rapid "lights out" sensation.
The problems. Tolerance develops within weeks, requiring dose escalation. REM sleep is chronically suppressed. Deep sleep initially increases but decreases with chronic use. Withdrawal produces rebound insomnia and vivid nightmares that can last 2 to 6 weeks. The net effect on sleep architecture is the worst of any option in this comparison. The withdrawal insomnia is also the most severe, which drives relapse and creates a self-reinforcing dependence cycle.
Best for. Short-term, occasional use for acute insomnia (once or twice, not nightly). Worst option for chronic nightly use.
Evidence quality. Moderate. Numerous studies on acute and chronic effects, though few large randomized controlled trials designed specifically for sleep outcomes.
Melatonin
How it works. Melatonin is not a sedative. This is the most common misunderstanding about it. Melatonin is a chronobiotic — it shifts the timing of your circadian clock. Your body naturally produces melatonin in the evening in response to darkness, signaling that nighttime has arrived and sleep should begin. Exogenous melatonin supplements this signal.
What it does well. Melatonin is excellent for circadian-related sleep problems: jet lag, delayed sleep phase, shift work adjustment, and the circadian disruption that occurs during cannabis withdrawal. It shifts your clock earlier so that you feel sleepy at the appropriate time. It does not suppress REM sleep. It does not build tolerance. It does not cause dependence or withdrawal. The safety profile is the best of any sleep intervention outside of behavioral treatments.
The problems. Melatonin does not knock you out. If your insomnia is driven by anxiety, pain, or hyperarousal, melatonin alone will not solve it — you will take it and still lie awake, leading to the conclusion that it "does not work." Additionally, most commercial melatonin products are dosed at 5 to 10 mg, which is 10 to 20 times the physiologically appropriate dose. Research suggests that 0.3 to 1 mg is optimal for most people. Higher doses can actually cause morning grogginess and may paradoxically disrupt sleep by overstimulating melatonin receptors.
Best for. Circadian timing problems. Cannabis users in withdrawal whose sleep is shifted late. Jet lag. Shift work.
Optimal use. 0.3 to 1 mg (not 5 to 10 mg), taken 30 to 60 minutes before target bedtime. Sustained-release formulations may help people who fall asleep but wake during the night.
Evidence quality. Strong for circadian adjustment. Weak for primary insomnia not related to circadian timing.
Diphenhydramine (Benadryl, ZzzQuil)
How it works. Diphenhydramine is a first-generation antihistamine that crosses the blood-brain barrier and blocks H1 histamine receptors. Histamine is a wake-promoting neurotransmitter, so blocking it produces drowsiness. It also has anticholinergic properties (blocks acetylcholine), which contribute to its sedating effect but also cause significant side effects.
What it does well. Diphenhydramine produces reliable, noticeable sedation on the first use. It is available over-the-counter, inexpensive, and familiar to most people. For a single night of acute insomnia (a stressful event, jet lag), it can be effective.
The problems. Tolerance develops faster than with cannabis — often within 3 to 7 days of nightly use. By day 4 or 5, the sedating effect is markedly reduced and many people increase the dose, beginning a rapid escalation cycle. Diphenhydramine suppresses REM sleep, similar to THC. Its anticholinergic properties impair memory consolidation during sleep, meaning even when it helps you sleep, the sleep is less cognitively restorative.
Most concerning is the long-term safety data. A 2015 study published in JAMA Internal Medicine found a dose-response relationship between cumulative anticholinergic use (including diphenhydramine) and increased risk of dementia. The American Academy of Sleep Medicine explicitly recommends against using diphenhydramine for chronic insomnia.
Best for. Single-night, occasional use only. Not appropriate for regular use.
Evidence quality. Moderate for acute use. Strong evidence against chronic use.
Trazodone
How it works. Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) originally developed as an antidepressant. At the lower doses used for sleep (25 to 100 mg, compared to 150 to 400 mg for depression), its primary effect is sedation through histamine H1 receptor antagonism and serotonin 5-HT2A receptor antagonism. The 5-HT2A antagonism is particularly relevant because it may actually promote deep sleep and REM sleep rather than suppressing them.
What it does well. Trazodone has a more favorable long-term sleep profile than either cannabis or diphenhydramine. It produces less REM suppression. Tolerance development is slower and less pronounced. It has low abuse potential — it does not produce euphoria or reinforcing effects that drive dependence in the way cannabis can. It is the most commonly prescribed off-label sleep medication in the United States, with extensive clinical experience supporting its use.
The problems. Side effects include next-day grogginess (especially at higher doses or when first starting), dry mouth, orthostatic hypotension (dizziness when standing), and in rare cases in males, priapism (prolonged erection requiring medical attention). It requires a prescription. Coming off trazodone after long-term use should be done gradually — while it does not produce withdrawal comparable to cannabis, abrupt discontinuation can cause rebound insomnia.
Best for. People with chronic insomnia who need a nightly sleep aid with a tolerable long-term profile. People transitioning off cannabis who need pharmacological support during the withdrawal insomnia period. People with comorbid depression and insomnia.
Evidence quality. Strong clinical experience. Limited large-scale randomized controlled trials specifically for primary insomnia, though widely used and well-understood pharmacologically.
Magnesium (Glycinate)
How it works. Magnesium is an essential mineral involved in over 300 enzymatic processes. For sleep, the relevant mechanisms include GABA receptor modulation (GABA is the brain's primary inhibitory neurotransmitter), muscle relaxation, and regulation of the stress response. Magnesium glycinate is the preferred form for sleep because glycine itself has calming properties and the glycinate form has better absorption and less GI disturbance than magnesium citrate or oxide.
What it does well. Magnesium has the mildest effect of any option on this list but also the lowest risk profile. There is no tolerance, no dependence, no withdrawal, no REM suppression, and no morning grogginess. Many people are mildly magnesium-deficient (estimates suggest 50% or more of the US population does not meet the recommended dietary allowance), and supplementation may correct a genuine deficiency that contributes to poor sleep.
The problems. The effect is subtle. If you are expecting melatonin-level or THC-level sleep impact, magnesium will disappoint. It works best for people whose sleep difficulty involves muscle tension, physical restlessness, or mild anxiety rather than severe insomnia. It is not a solution for clinical insomnia. High doses can cause loose stools, though glycinate is better tolerated than other forms.
Best for. Mild sleep difficulty. General relaxation. Muscle tension or restlessness that interferes with sleep. As an adjunct to other interventions. During cannabis withdrawal to support overall nervous system calming.
Evidence quality. Moderate for sleep in magnesium-deficient populations. Weak for sleep in magnesium-replete individuals.
The Comparison Matrix
| Factor | Cannabis (THC) | Melatonin | Diphenhydramine | Trazodone | Magnesium |
|---|---|---|---|---|---|
| Speed of onset | Fastest | Moderate (30-60 min) | Fast (20-30 min) | Moderate (30-60 min) | Slow (gradual) |
| Sleep architecture | Worst (REM suppressed) | Preserved | Poor (REM suppressed) | Good (may enhance deep sleep) | Preserved |
| Tolerance risk | High (weeks) | Minimal | Highest (3-7 days) | Low-moderate | None |
| Dependence risk | Moderate-high | None | Low-moderate | Low | None |
| Withdrawal severity | Severe (2-6 weeks) | None | Mild-moderate | Mild (if tapered) | None |
| Long-term safety | Concerns | Excellent | Poor (dementia risk) | Good | Excellent |
| Availability | Dispensary/varies | OTC | OTC | Prescription | OTC |
What This Means for Cannabis Users
If you are currently using cannabis for sleep and considering alternatives, the comparison reveals several practical insights.
Melatonin is not a THC replacement but it is an excellent complement during the transition. During cannabis withdrawal, your circadian clock is often delayed and your melatonin secretion is recovering from THC-mediated suppression. Low-dose melatonin (0.3 to 1 mg) 30 to 60 minutes before your target bedtime can help re-anchor your circadian rhythm without introducing new dependence. For more detail on melatonin during withdrawal, see melatonin during weed withdrawal.
Diphenhydramine is not a good bridge. It may be tempting to grab ZzzQuil during the first week of cannabis withdrawal when insomnia is worst, but tolerance develops so rapidly that you will be in the same pattern within a week — a substance that initially helps but quickly stops working and adds its own withdrawal. The AASM's recommendation against chronic use should be taken seriously.
Trazodone is worth discussing with your doctor if you are attempting to quit cannabis and the withdrawal insomnia is severe enough to threaten your ability to maintain abstinence. A short course of low-dose trazodone (25 to 50 mg) during the 2 to 4 week peak withdrawal period can provide enough sleep support to get through the worst of it without introducing the tolerance and architecture problems that cannabis created.
Magnesium is a low-risk addition that may modestly improve overall relaxation and sleep quality. It is not powerful enough to counteract severe withdrawal insomnia on its own but can contribute as part of a multi-component approach alongside sleep hygiene, melatonin, and stress management.
None of these match CBT-I. Cognitive behavioral therapy for insomnia outperforms every pharmacological option in long-term studies. If chronic insomnia is the underlying issue, CBT-I addresses the root cause — the behavioral and cognitive patterns that maintain insomnia — without any substance at all. Every option on this list, including cannabis, is treating symptoms. CBT-I treats the problem.
The Bottom Line
Head-to-head comparison of cannabis (THC), melatonin, diphenhydramine (Benadryl), trazodone, and magnesium for sleep. Cannabis: fastest perceived onset, worst long-term architecture (REM suppression, tolerance in weeks, withdrawal insomnia), Schedule I. Melatonin: not a sedative but a chronobiotic (shifts circadian timing); optimal dose 0.3-1 mg (not 5-10 mg commercial doses); no tolerance/dependence/withdrawal; best for circadian-related insomnia, not hyperarousal. Diphenhydramine: anticholinergic sedative; tolerance within 3-7 days (faster than THC); suppresses REM; impairs memory consolidation; AASM recommends against regular use; linked to increased dementia risk at chronic doses. Trazodone: serotonin antagonist/reuptake inhibitor; 25-100 mg sleep dose (lower than antidepressant dose); less REM suppression than THC or diphenhydramine; lower abuse potential; side effects include next-day grogginess, orthostatic hypotension, rare priapism. Magnesium glycinate: GABA receptor modulation, muscle relaxation; 200-400 mg; mildest effect but lowest risk; best for tension/restlessness/deficiency. Overall ranking by profile: long-term safety (magnesium > melatonin > trazodone > cannabis > diphenhydramine); sleep architecture preservation (magnesium > melatonin > trazodone > cannabis ≈ diphenhydramine); tolerance risk (melatonin = magnesium < trazodone < cannabis < diphenhydramine).
Frequently Asked Questions
Sources & References
- 1RTHC-00640·Zajicek, John Peter et al. (2012). “Cannabis Extract Nearly Doubled the Rate of Muscle Stiffness Relief in Multiple Sclerosis.” Journal of neurology.Study breakdown →PubMed →↩
- 2RTHC-00205·Rog, David J et al. (2005). “Cannabis-Based Spray Significantly Reduced MS Central Pain and Sleep Problems in Rigorous Trial.” Neurology.Study breakdown →PubMed →↩
- 3RTHC-07899·Walczyńska-Dragon, Karolina et al. (2025). “Topical CBD Gel Improved Sleep and Reduced Migraine Disability in Bruxism Patients.” Pharmaceuticals (Basel.Study breakdown →PubMed →↩
- 4RTHC-07987·Xu, Carol et al. (2025). “Recreational Cannabis Laws Are Associated With People Sleeping About 5 Minutes Less.” AJPM focus.Study breakdown →PubMed →↩
- 5RTHC-07860·Velzeboer, Rob et al. (2025). “Cannabis Doesn't Consistently Change Sleep Patterns — But Withdrawal Clearly Disrupts Sleep.” Sleep medicine reviews.Study breakdown →PubMed →↩
- 6RTHC-02212·Orsolini, Laura et al. (2019). “Cannabis for PTSD in 2019: The Systematic Evidence Was Still Thin Despite Growing Interest.” Medicina (Kaunas).Study breakdown →PubMed →↩
- 7RTHC-00797·Gates, Peter J. et al. (2014). “39 Studies Later, the Evidence That Cannabis Helps You Sleep Is Weaker Than You Think.” Sleep Medicine Reviews.Study breakdown →PubMed →↩
- 8RTHC-00641·Zhornitsky, Simon et al. (2012). “Systematic Review: What CBD Does (and Does Not) Do in Humans.” Pharmaceuticals (Basel.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Multiple sclerosis and extract of cannabis: results of the MUSEC trial.
Zajicek, John Peter · 2012
The MUSEC trial randomized 279 MS patients across 22 UK centers to oral cannabis extract or placebo.
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Rog, David J · 2005
Sixty-six MS patients with central pain (59 with dysesthetic pain, 7 with painful spasms) participated in a 5-week randomized, double-blind, placebo-controlled trial of a THC:CBD oromucosal spray.
Expanding the Therapeutic Profile of Topical Cannabidiol in Temporomandibular Disorders: Effects on Sleep Quality and Migraine Disability in Patients with Bruxism-Associated Muscle Pain.
Walczyńska-Dragon, Karolina · 2025
Both 5% and 10% CBD gel groups showed statistically significant improvements in Pittsburgh Sleep Quality Index and Migraine Disability Assessment scores compared to placebo (p < threshold), with 10% CBD showing the strongest effects.
The Effects of Cannabis Access Laws on Sleep in the U.S.
Xu, Carol · 2025
Recreational cannabis laws reduced sleep by 5.37 minutes per night (99% CI: 0.91-9.83), primarily by delaying sleep onset by 7.14 minutes without changing wake times.
Cannabis and sleep architecture: A systematic review and meta-analysis.
Velzeboer, Rob · 2025
Across 18 studies (9 in meta-analysis), cannabis administration did not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging.
Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review
Orsolini, Laura · 2019
This systematic review gathered everything published through May 2019 on cannabis and synthetic cannabinoids for PTSD.
The effects of cannabinoid administration on sleep: a systematic review of human studies
Gates, Peter J. · 2014
Across 39 human studies that administered a cannabinoid and measured sleep quantitatively, results did not converge.
Cannabidiol in humans-the quest for therapeutic targets.
Zhornitsky, Simon · 2012
The review identified 34 studies: 16 in healthy subjects and 18 in clinical populations covering MS, schizophrenia, bipolar mania, social anxiety, pain, cancer, Huntington's disease, insomnia, and epilepsy. Key findings included: high inhaled/IV doses of CBD were needed to block THC effects.